<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>A. Velle | Romualdi Lab</title>
    <link>/author/a.-velle/</link>
      <atom:link href="/author/a.-velle/index.xml" rel="self" type="application/rss+xml" />
    <description>A. Velle</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â© Research Group</copyright><lastBuildDate>Sun, 01 Jan 2023 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hud8b169d6400d4e9e77db720aa3284c6d_12325_512x512_fill_lanczos_center_2.png</url>
      <title>A. Velle</title>
      <link>/author/a.-velle/</link>
    </image>
    
    <item>
      <title>A comprehensive investigation of histotype-specific microRNA and their variants in Stage I epithelial ovarian cancers</title>
      <link>/publication/2023-01-01_a_comprehensive_inve/</link>
      <pubDate>Sun, 01 Jan 2023 00:00:00 +0000</pubDate>
      <guid>/publication/2023-01-01_a_comprehensive_inve/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis</title>
      <link>/publication/2022-01-01_copy_number_alterati/</link>
      <pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate>
      <guid>/publication/2022-01-01_copy_number_alterati/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
